Article Details

Non-Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2023 - Digital Journal

Retrieved on: 2023-12-04 20:50:49

Tags for this article:

Click the tags to see associated articles and topics

Non-Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2023 - Digital Journal. View article details on HISWAI: https://www.digitaljournal.com/pr/news/getnews/non-small-cell-lung-cancer-pipeline-drugs-analysis-report-2023-fda-approvals-clinical-trials-therapies-moa-roa-by-delveinsight-roche-astrazeneca-bristol-myers-squibb-company-merck-novartis

Excerpt

... BioNTech SE, Cellular Biomedicine Group, Shenzhen TargetRx, Inc., Iovance Biotherapeutics, Revolution Medicines, Inc, Genmab, Incyte Corporation ...

Article found on: www.digitaljournal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up